期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 79, 期 7, 页码 682-694出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2021.12.010
关键词
atrial fibrillation; autonomous nervous system; neuromodulation; vagus nerve
This review critically appraised the current evidence on autonomic neuromodulation therapies (ANMTs) for preventing postoperative atrial fibrillation (POAF) after cardiac surgery. The meta-analysis found that ANMTs can reduce the incidence and burden of POAF, shorten length of stay, and decrease inflammatory response. These findings provide a foundation for future larger and comparative trials of ANMTs.
Autonomic neuromodulation therapies (ANMTs) (ie, ganglionated plexus ablation, epicardial injections for temporary neurotoxicity, low-level vagus nerve stimulation [LL-VNS], stellate ganglion block, baroreceptor stimulation, spinal cord stimulation, and renal nerve denervation) constitute an emerging therapeutic approach for arrhythmias. Very little is known about ANMTs' preventive potential for postoperative atrial fibrillation (POAF) after cardiac surgery. The purpose of this review is to summarize and critically appraise the currently available evidence. Herein, the authors conducted a systematic review of 922 articles that yielded 7 randomized controlled trials. In the meta-analysis, ANMTs reduced POAF incidence (OR: 0.37; 95% CI: 0.25 to 0.55) and burden (mean difference [MD]:-3.51 hours; 95% CI:-6.64 to-0.38 hours), length of stay (MD:-0.82 days; 95% CI:-1.59 to-0.04 days), and interleukin-6 (MD:-79.92 pg/mL; 95% CI:-151.12 to-8.33 pg/mL), mainly attributed to LL-VNS and epicardial injections. Moving forward, these findings establish a base for future larger and comparative trials with ANMTs, to optimize and expand their use. (J Am Coll Cardiol 2022;79:682-694) (c) 2022 by the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据